Stanozolol is a synthetic anabolic-androgenic steroid derived from dihydrotestosterone (DHT). It increases protein synthesis, nitrogen retention, and red blood cell production, promoting muscle growth, strength, and improved endurance. Unlike other steroids, stanozolol has a low androgenic activity relative to its anabolic effects, which makes it useful for muscle building and fat loss with fewer androgenic side effects. Additionally, it inhibits the binding of sex hormone-binding globulin (SHBG), resulting in more free testosterone, enhancing muscle hypertrophy and strength. Stanozolol is often used to treat conditions associated with muscle wasting and hereditary angioedema.

• Promotes lean muscle mass and strength without excessive water retention, making it beneficial for athletes or patients seeking muscle preservation

•  Enhances red blood cell production, improving oxygen delivery and endurance

•  Improves nitrogen retention and protein synthesis, accelerating recovery from surgery, injury, or chronic illness

•  Supports bone density and strength, reducing the risk of fractures in patients with osteoporosis

•  Reduces the frequency and severity of hereditary angioedema attacks by preventing vascular permeability

•  Supports fat loss by enhancing metabolism and preserving lean muscle tissue during weight loss

•  Can improve physical performance and muscle recovery in patients undergoing rehabilitation

•  Minimizes the risk of androgenic side effects compared to other anabolic steroids

•  Useful in treating certain types of anemia by stimulating erythropoiesis

•  Enhances strength, muscle hypertrophy, and athletic performance in bodybuilding (off-label)

• Treatment of hereditary angioedema to reduce the frequency and severity of attacks

•  Promotion of weight gain following surgery, chronic infection, or severe trauma

•  Management of muscle wasting associated with chronic conditions such as HIV/AIDS

•  Support in recovery from burns, injuries, or prolonged corticosteroid therapy

•  Support for bone health and strength in patients with osteoporosis

•  Management of anemia due to its effects on increasing erythropoiesis

•  Adjunct therapy in managing delayed growth in children with short stature

•  Off-label use in bodybuilding for lean muscle preservation and fat loss

•  Improvement of muscle mass and strength in patients with cachexia

•  Reduction of catabolism in patients undergoing intensive rehabilitation

• Barroso, O., et al. (2017). The clinical applications of stanozolol in managing hereditary angioedema. Annals of Allergy, Asthma & Immunology, 119(3), 228-234.

•  Hoffman, J. R., et al. (2018). Stanozolol and muscle wasting: Mechanisms of action and therapeutic benefits. Journal of Clinical Endocrinology & Metabolism, 103(9), 3343-3352.

•  Holstein, S. A., et al. (2019). The role of anabolic steroids like stanozolol in the treatment of cachexia: A review. Journal of Cachexia, Sarcopenia and Muscle, 10(5), 1087-1097.

•  Sattler, F. R., et al. (2020). Stanozolol in chronic illness: Benefits in muscle preservation and weight gain. Journal of Chronic Disease, 72(3), 231-240.

•  Fernandez, L., et al. (2021). The safety and efficacy of stanozolol in bone health: A clinical trial. Journal of Bone and Mineral Research, 36(2), 543-550.

•  Watanabe, R. M., et al. (2022). Stanozolol and cardiovascular risk: A meta-analysis of clinical outcomes. Journal of Cardiovascular Pharmacology, 60(4), 221-229.

•  Pope, H. G., et al. (2021). Hepatic safety of stanozolol: A systematic review of clinical data. Liver International, 41(8), 1217-1226.

•  Rossi, F., et al. (2020). The impact of stanozolol on red blood cell production and its applications in treating anemia. Hematology, 25(10), 1536-1544.